EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Robotics and Aseptic Processing in View of Regulatory Requirements

Andrea Tanzini, Marco Ruggeri iD, Eleonora Bianchi, Caterina Valentino, Barbara Vigani, Franca Ferrari iD, Silvia Rossi iD, Hermes Giberti iD, Giuseppina Sandri iD

Pharmaceutics · 24.05.2023 · 15 (6) · 1581

DOI: 10.3390/pharmaceutics15061581 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 24.05.2023. Verfasst von Andrea Tanzini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Staubli Robotics, Staubli Italia S.p.A, Via Rivera 55, 20841 Carate Brianza, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several nanomedicine based medicinal products recently reached the market thanks to the drive of the COVID-19 pandemic. These products are characterized by criticality in scalability and reproducibility of the batches, and the manufacturing processes are now being pushed towards continuous production to face these challenges. Although the pharmaceutical industry, because of its deep regulation, is characterized by slow adoption of new technologies, recently, the European Medicines Agency (EMA) took the lead in pushing for process improvements using technologies already established in other manufacturing sectors. Foremost among these technologies, robotics is a technological driver, and its implementation in the pharma field should cause a big change, probably within the next 5 years. This paper aims at describing the regulation changes mainly in aseptic manufacturing and the use of robotics in the pharmaceutical environment to fulfill GMP (good manufacturing practice). Special attention is therefore paid at first to the regulatory aspect, explaining the reasons behind the current changes, and then to the use of robotics that will characterize the future of manufacturing especially in aseptic environments, moving from a clear overview of robotics to the use of automated systems to design more efficient processes, with reduced risk of contamination. This review should clarify the regulation and technological scenario and provide pharmaceutical technologists with basic knowledge in robotics and automation, as well as engineers with regulatory knowledge to define a common background and language, and enable the cultural shift of the pharmaceutical industry.

Schlagwörter

Stichwörter der Autor:innen

GMPannex 1automationnanomedicinespharmaceutical processesroboticssterile manufacturing

Autor:innen und Institutionen

  • Staubli Robotics, Staubli Italia S.p.A, Via Rivera 55, 20841 Carate Brianza, Italy.
  • Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
  • Department of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Ferrata, 27100 Pavia, Italy.

ORCID-Profile: Marco Ruggeri, Franca Ferrari, Silvia Rossi, Hermes Giberti, Giuseppina Sandri

Zitieren

APA

Tanzini, A., Ruggeri, M., Bianchi, E., Valentino, C., Vigani, B., Ferrari, F., Rossi, S., Giberti, H., & Sandri, G. (2023). Robotics and Aseptic Processing in View of Regulatory Requirements. Pharmaceutics, 15(6), 1581. https://doi.org/10.3390/pharmaceutics15061581

Vancouver

Tanzini A, Ruggeri M, Bianchi E, Valentino C, Vigani B, Ferrari F, et al. Robotics and Aseptic Processing in View of Regulatory Requirements. Pharmaceutics. 2023;15(6):1581. doi:10.3390/pharmaceutics15061581

BibTeX
@article{Tanzini2023,
  author = {Tanzini, Andrea and Ruggeri, Marco and Bianchi, Eleonora and Valentino, Caterina and Vigani, Barbara and Ferrari, Franca and Rossi, Silvia and Giberti, Hermes and Sandri, Giuseppina},
  title = {Robotics and Aseptic Processing in View of Regulatory Requirements},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1581},
  doi = {10.3390/pharmaceutics15061581}
}
Kostenlos starten →